Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_assertion type Assertion NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_head.
- NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_assertion description "[Patients with BRAFV600E/K-driven melanoma respond to the BRAF inhibitor vemurafenib due to subsequent deactivation of the proliferative RAS/RAF/MEK/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_provenance.
- NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_assertion evidence source_evidence_literature NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_provenance.
- NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_assertion SIO_000772 25329694 NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_provenance.
- NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_assertion wasDerivedFrom befree-2016 NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_provenance.
- NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_assertion wasGeneratedBy ECO_0000203 NP1230712.RAkhklFY9yeLTDqFFBXaZnGvQP10-mELX6p3jJJkBI_U4130_provenance.